{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:10:10Z","timestamp":1793729410051,"version":"4.6.1"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.26312","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T18:10:12Z","timestamp":1605550212000},"page":"e2026312","source":"Crossref","is-referenced-by-count":72,"title":["Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis"],"prefix":"10.1001","volume":"3","author":[{"given":"Ian","family":"Poon","sequence":"first","affiliation":[{"name":"Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darby","family":"Erler","sequence":"additional","affiliation":[{"name":"Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roi","family":"Dagan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Florida, Jacksonville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin J.","family":"Redmond","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Foote","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Badellino","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tithi","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[{"name":"Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshetu G.","family":"Atenafu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[{"name":"Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"issue":"7","key":"zoi200856r1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/bjs.v84:7","article-title":"Long-term survival following resection of colorectal hepatic metastases.","volume":"84","author":"Jaeck","year":"1997","journal-title":"Br J Surg"},{"issue":"1","key":"zoi200856r2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.","volume":"113","author":"Pastorino","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"zoi200856r3","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ijrobp.2011.08.036","article-title":"Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.","volume":"83","author":"Milano","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"zoi200856r4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrclinonc.2014.96","article-title":"The oligometastatic state: separating truth from wishful thinking.","volume":"11","author":"Palma","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"zoi200856r5","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"18","key":"zoi200856r6","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study.","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"issue":"10185","key":"zoi200856r7","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"25","key":"zoi200856r8","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial.","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"issue":"5","key":"zoi200856r9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial.","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi200856r10","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non\u2013small-cell lung cancer: a phase 2 randomized clinical trial.","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"issue":"4","key":"zoi200856r11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/COC.0000000000000169","article-title":"Definitive stereotactic body radiotherapy (SBRT) for extracranial oligometastases: an international survey of >1000 radiation oncologists.","volume":"40","author":"Lewis","year":"2017","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"zoi200856r12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.clon.2012.04.006","article-title":"The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.","volume":"24","author":"Sahgal","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"zoi200856r13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41571-018-0119-7","article-title":"Time to abandon single-site irradiation for inducing abscopal effects.","volume":"16","author":"Brooks","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"zoi200856r14","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2217\/fon-2016-0479","article-title":"A multinational report of technical factors on stereotactic body radiotherapy for oligometastases.","volume":"13","author":"Redmond","year":"2017","journal-title":"Future Oncol"},{"issue":"5","key":"zoi200856r15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3109\/0284186X.2015.1118659","article-title":"A multi-national report on stereotactic body radiotherapy for oligometastases: patient selection and follow-up.","volume":"55","author":"Dagan","year":"2016","journal-title":"Acta Oncol"},{"issue":"10162","key":"zoi200856r16","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","article-title":"Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.","volume":"392","author":"Parker","year":"2018","journal-title":"Lancet"},{"issue":"6282","key":"zoi200856r17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process.","volume":"352","author":"Turajlic","year":"2016","journal-title":"Science"},{"issue":"10185","key":"zoi200856r18","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/S0140-6736(19)30278-8","article-title":"SABR-COMET: harbinger of a new cancer treatment paradigm.","volume":"393","author":"Loo","year":"2019","journal-title":"Lancet"},{"key":"zoi200856r19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fonc.2019.00543","article-title":"A review of ongoing trials of stereotactic ablative radiotherapy for oligometastatic cancers: where will the evidence lead?","volume":"9","author":"Al-Shafa","year":"2019","journal-title":"Front Oncol"},{"issue":"1","key":"zoi200856r20","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"zoi200856r21","article-title":"Immunomodulatory effects of stereotactic body radiation therapy: preclinical insights and clinical opportunities.","author":"Marciscano","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2772997\/poon_2020_oi_200856_1604932492.00598.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T18:10:16Z","timestamp":1605550216000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2772997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.26312","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]}}}